LHC Group has implemented a targeted program specifically designed for patients with cardiopulmonary conditions such as heart failure, chronic obstructive pulmonary disease (COPD), and other related illnesses. This initiative aims to provide personalized care plans, medication management, and education to help these patients manage their conditions effectively and reduce hospital readmissions.